SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Rejko Krüger, Rüdiger Hilker, Christian Winkler, Michael Lorrain, Matthias Hahne, Christoph Redecker, Paul Lingor, Wolfgang H. Jost, Advanced stages of PD: interventional therapies and related patient-centered care, Journal of Neural Transmission, 2015,

    CrossRef

  2. 2
    Anil Venkitachalam, Adriana Lazarescu, Oksana Suchowersky, Enteral Levodopa Therapy in Advanced Parkinson's Disease with Gastroparesis, Movement Disorders Clinical Practice, 2015, 2, 2
  3. 3
    Mark F. Lew, John T. Slevin, Rejko Krüger, Juan Carlos Martínez Castrillo, Krai Chatamra, Jordan S. Dubow, Weining Z. Robieson, Janet A. Benesh, Victor S.C. Fung, Initiation and dose optimization for levodopa-carbidopa intestinal gel: Insights from phase 3 clinical trials, Parkinsonism & Related Disorders, 2015, 21, 7, 742

    CrossRef

  4. 4
    Levodopa/carbidopa, Reactions Weekly, 2015, 1547, 1, 170

    CrossRef

  5. 5
    Oluwadamilola O Ojo, Hubert H Fernandez, Levodopa/carbidopa intestinal gel: an effective formulation for the management of advanced Parkinson's disease, Future Neurology, 2015, 10, 3, 191

    CrossRef

  6. 6
    Maríateresa Buongiorno, Francesca Antonelli, Ana Cámara, Victor Puente, Oriol de Fabregues-Nebot, Jorge Hernandez-Vara, Matilde Calopa, Berta Pascual-Sedano, Antonia Campolongo, Francesc Valldeoriola, Eduardo Tolosa, Jaime Kulisevsky, Maria Jose Martí, Long-term response to continuous duodenal infusion of levodopa/carbidopa gel in patients with advanced Parkinson disease: The Barcelona registry, Parkinsonism & Related Disorders, 2015, 21, 8, 871

    CrossRef

  7. 7
    Manuela Pilleri, Angelo Antonini, Therapeutic strategies to prevent and manage dyskinesias in Parkinson’s disease, Expert Opinion on Drug Safety, 2015, 14, 2, 281

    CrossRef

  8. 8
    Toshio Nakaki, 2015,

    CrossRef

  9. 9
    H. Baas, J. Claßen, M. Gerlach, M. Schwarz, P. Themann, D. Woitalla, W. Jost, Should the maximum daily doses of levodopa be limited to 400mg/die?, Basal Ganglia, 2014, 4, 1, 29

    CrossRef